Abstract
Loss-of-function mutations in the thyrotropin receptor (TSHR) gene were described as a syndrome characterized by thyroid hyposensivity to biologically active TSH, ranging from euthyroid to severe hypothyroidism. In Japanese, a common mutation in the TSHR gene is R450H, which demonstrated moderately impaired receptor function. We studied six subjects of Japanese origin whose major abnormality was persistent hyperthyrotropinemia by genetic sequence analysis of the TSHR gene. Three subjects were homozygous for the R450H mutation, whereas the three remaining subjects were single heterozygous. Homozygous subjects displayed mild hypothyroidism confirmed by moderately elevated basal TSH levels and excessive TSH response to TRH administration. Heterozygous subjects also demonstrated fully or partially compensated hypothyroidism, but less severe than that of homozygous subjects. More frequent involvement of the R450H mutation in the TSHR gene in Japanese was identified. In addition, a good correlation between phenotype and genotype was demonstrated in respect to biochemical analysis and drug dosage. Our observations showed clinical significance of heterozygosity associated with compensated hypothyroidism in spite of only mildly impaired receptor function.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Devos, H., Rodd, C., Gagne, N., Laframboise, R., and Van Vliet, G. (1999). J. Clin. Endocrinol. Metab. 84, 2502–2506.
Castanet, M., Polak, M., Bonaiti-Pellie, C., Lyonnet, S., Czernichow, P., and Leger, J. (2001). J. Clin. Endocrinol. Metab. 86, 2009–2014.
Olivieri, A., Stazi, M. A., Mastroiacovo, P., et al. (2002). J. Clin. Endocrinol. Metab. 87, 557–562.
Grant, D. B., Smith, I., Fuggle, P. W., Toker, S., and Chapple, J. (1992). Arch. Dis. Child. 67, 87–90.
Castaner, M., Lyonnet, S., Bonaiti-Pellie, C., Polak, M., Czernichow, P., and Leger, J. (2000). N. Engl. J. Med. 343, 441–442.
Vassart, G. and Dumont, J. E. (1992). Endocr. Rev. 13, 596–611.
Libert, F., Passage, E., Lefort, A., Vassart, G., and Mattiei, M. G. (1990). Cytogenet. Cell Genet. 54, 82–83.
Gross, B., Misrahi, M., Sar, S., and Milgrom, E. (1991). Biochem. Biophys. Res. Commun. 177, 679–687.
Corvilain, B., Van Sande, J., Dumont, J. E., and Vassart, G. (2001). Clin. Endocrinol. 55, 143–158.
Sunthornthepvarakul, T., Hayashi, Y., and Refetoff, S. (1995). N. Engl. J. Med. 332, 155–160.
De Roux, N., Misrahi, M., Brauner, R., et al. (1996). J. Clin. Endocrinol. Metab. 81, 4229–4235.
Abramowicz, M. J., Duprez, L., Panna, J., Vassart, G., and Heinrich, C. (1997). J. Clin. Invest. 99, 3018–3024.
Biebermann, H., Schoneberg, T., Krude, H., Schuktz, G., Gudermann, T., and Gruters, A. (1997). J. Clin. Endocrinol. Metab. 82, 3471–3480.
Clifton-Bligh, R. J., Gregory, J. W., Ludgate, M., et al. (1997). J. Clin. Endocrinol. Metab. 82, 1094–1100.
Gagne, N., Parma, J., Deal, C., Vassart, G., and Van Vliet, G. (1998). J. Clin. Endocrinol. Metab. 83, 1771–1775.
Russo, D., Betterle, C., Arturi, F., Chiefari, E., Girelli, M. E., and Filetti, S. (2000). J. Clin. Endocrinol. Metab. 85, 4238–4242.
Tonacchera, M., Agretti, P., Pinchera, A., et al. (2000). J. Clin. Endocrinol. Metab. 85, 1001–1008.
Nagashima, T., Murakami, M., Onigata, K., et al. (2001). Thyroid 11, 551–559.
Alberti, L., Proverbio, M. C., Costagliola, S., et al. (2002). J. Clin. Endocrinol. Metab. 87, 2549–2555.
Richter-Unruh, A., Hauffa, B. P., Pfarr, N., and Pohlenz, J. (2004). Thyroid 14, 971–974.
Camilot, M., Teofoli, F., Gandini, A., et al. (2005) Clin. Endocrinol. 63, 146–151.
Fricke-Otto, S., Pfarr, N., Mublenberg, R., Pohlenz, J. (2005). Exp. Clin. Endocrinol. Diabetes 113, 582–585.
Tsunekawa, K., Onigata, K., Morimura, T., et al. (2006). Thyroid 16, 471–479.
Van Sande, J., Panna, J., Tonacchera, M., Swillens, S., Dumont, J., and Vassart, G. (1995). J. Clin. Endocrinol. Metab. 80, 2577–2585.
De Felice, M. and Di Lauro, R. (2004). Endocr. Rev. 25, 722–746.
Park, S. M., Clifton-Bligh, R. J., Betts, P., and Chatterjee, V. K. K. (2004). Clin. Endocrinol. 60, 220–227.
Shibayama, K., Ohyama, Y., Hishinuma, A., et al. (2005). Pediatr. Int. 47, 105–108.
Cuddhihy, R. M., Dutton, C. M., and Bahn, R. S. (1995). Thyroid 5, 89–95.
Gabriel, E. M., Bergert, E. R., Grant, C. S., Van Heerden, J. A., Thompson, G. B., and Morris, J. C. (1999). J. Clin. Endocrinol. Metab. 84, 3328–3335.
Rapaport, R., Sills, I., Patel, U., et al. (1993). J. Clin. Endocrinol. Metab. 77, 889–894.
Daliva, A. L., Linder, B., DiMartino-Nardi, J., and Saenger, P. (2000). J. Pediatr. 136, 53–56.
Pop, V. J., Kuijpens, J. L., Van Baar, A. L., et al. (1999). Clin. Endocrinol. 50, 149–155.
Haddow, J. E., Palomaki, G. E., Allan, W. C., et al. (1999). N. Engl. J. Med. 341, 549–555.
De Roux, N., Misrahi, M., Chatelain, N., Gross, B., and Milgrom, E. (1996). Mol. Cell. Endocrinol. 117, 253–256.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kanda, K., Mizuno, H., Sugiyama, Y. et al. Clinical significance of heterozygous carriers associated with compensated hypothyroidism in R450H, a common inactivating mutation of the thyrotropin receptor gene in Japanese. Endocr 30, 383–388 (2006). https://doi.org/10.1007/s12020-006-0018-z
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s12020-006-0018-z